Submitted July 21, 2008
Accepted November 12, 2008
Caveolin-1 dependent apoptosis induced by fibrin degradation products
Yi-He Guo, Irene Hernandez, Berend Isermann, Tae-bong Kang, Leonid Medved, Rashmi Sood, Edward J Kerschen, Trudy Holyst, Michael W. Mosesson, and Hartmut Weiler*
Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI, United States
Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel
Center for Vascular and Inflammatory Diseases, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United States
* Corresponding author; email: hartmut.weiler{at}bcw.edu.
In mice lacking the blood coagulation regulator thrombomodulin, fibrinolytic degradation products (FDP) of fibrin induce apoptotic cell death of a specialized cell type in the placenta, polyploid trophoblast giant cells. Here, we document that this bioactivity of FDP is conserved in human FDP, is not limited to trophoblast cells, and is associated with the A
-chain of fibrin fragment E (FnE). The majority of pro-apoptotic activity is RGD-independent and requires caveolin-1-dependent cellular internalization of FnE. Internalization through caveoli is mediated by an epitope comprised within A
52-81, that is necessary and sufficient for cellular uptake of FnE. A
52-81 does not cause apoptosis itself, and competitively inhibits FnE internalization and apoptosis-induction. Apoptotic activity per se resides within A
17-37 and requires the N-terminal neo-epitope generated by release of fibrinopeptide A. Cellular internalization of FnE elicits depression of mitochondrial function and consequent apoptosis that is strictly dependent on the activity of caspases 9 and 3. These findings describe the molecular details of a novel mechanism linking fibrin degradation to cell death in the placenta, which may also contribute to pathological alterations in non-placental vascular beds that are associated with fibrinolysis.